Freemont Management S.A. cut its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 55.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 100,000 shares of the medical device company’s stock after selling 124,200 shares during the period. DexCom accounts […]